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Abstract
Background: Recent incidents, such as the SARS and influenza epidemics, have highlighted the need for readily
available antiviral drugs. One important precursor currently used for the production of Relenza, an antiviral product
from GlaxoSmithKline, is N-acetylneuraminic acid (NeuNAc). This substance has a considerably high market price
despite efforts to develop cost-reducing (biotechnological) production processes. Hypocrea jecorina (Trichoderma
reesei) is a saprophyte noted for its abundant secretion of hydrolytic enzymes and its potential to degrade chitin to
its monomer N-acetylglucosamine (GlcNAc). Chitin is considered the second most abundant biomass available on
earth and therefore an attractive raw material.
Results: In this study, we introduced two enzymes from bacterial origin into Hypocrea, which convert GlcNAc into
NeuNAc via N-acetylmannosamine. This enabled the fungus to produce NeuNAc from the cheap starting material
chitin in liquid culture. Furthermore, we expressed the two recombinant enzymes as GST-fusion proteins and
developed an enzyme assay for monitoring their enzymatic functionality. Finally, we demonstrated that Hypocrea
does not metabolize NeuNAc and that no NeuNAc-uptake by the fungus occurs, which are important prerequisites
for a potential production strategy.
Conclusions: This study is a proof of concept for the possibility to engineer in a filamentous fungus a bacterial
enzyme cascade, which is fully functional. Furthermore, it provides the basis for the development of a process for
NeuNAc production as well as a general prospective design for production processes that use saprophytes as
whole-cell catalysts.
Background
NeuNAc is the most prevalent exponent of sialic acids [1].
In mammals, sialic acids are usually found as terminal
residues of glycol conjugates on the outermost cell surface.
As a result of their location and their negative carboxylate
functionality, sialic acids play important roles in mediating
cellular recognition and adhesion processes [2] and in the
infection cycles of severe viral diseases, such as influenza
viruses A and B [3]. In these cases, de novo-synthesized
viral particles attach to their respective sialic acids at the
cell surface. Neuraminidase (sialidase) activity is needed
for the propagation of the virus in the host. Consequently,
sialic acid derivatives are successfully applied in the ther-
apy of such virus-related diseases. One well-known pro-
duct that functions as a neuraminidase inhibitor is
Relenza. Its active pharmaceutical ingredient is Zanamivir,
which is a direct derivative of the NeuNAc precursor [4].
Traditionally, NeuNAc is prepared through extraction
from natural sources, such as bird nests, milk, or eggs [5],
through the hydrolysis of colominic acid (a homopolymer
of NeuNAc) in a culture broth of Escherichia coli K1 [6],
or through chemical synthesis [7]. Methods for NeuNAc
production have included a chemo-enzymatic process
[8,9], a two-enzyme reaction process [10,11], a biotransfor-
mation process using E. coli [12], and an E. coli whole-cell
system [13]. However, the requirement for ATP or an
excess of pyruvate and the subsequent expensive down-
stream processing has kept the costs of NeuNAc produc-
tion considerably high (current market price is $100/g).
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available on earth [14]. The estimated annual biosynthesis
of chitin is more than 10
11 tons in marine waters alone
[15]. Unlike cellulose, the other dominant biopolymer,
chitin can serve as a source for both carbon and nitrogen
(C:N = 8:1) [16]. This property suggests that chitin is an
optimal resource for the production of NeuNAc (C:N =
1 1 : 1 )b e c a u s en oa d d i t i o n a ln i t r o g e nw o u l dn e e dt ob e
applied as it would be if glucose or cellulose were used as
raw material. Chitin is found in the exoskeletons of arthro-
pods, such as crustaceans (including crab, lobster, and
shrimp) and insects (including ants and beetles), the cell
walls of fungi, the radula of mollusks, and the beaks of
cephalopods (including squid and octopi). This polymer is
composed of b-(1,4)-linked units of the amino sugar
N-acetylglucosamine (GlcNAc) that is currently produced
using hydrolysis of deproteinized and demineralized crusta-
cean shells [17]. Chitinolytic enzymes from fungi of the
genus Hypocrea have been extensively studied for decades
[18]. More recently, the chitinolytic enzyme system of
H. jecorina has been studied using genome-wide analysis
[19,20]. Unlike their bacterial counterparts (e.g., Serratia
marcescens [21]), Hypocrea chitinolytic preparations have a
high ratio of exochitinase to endochitinase activity and
almost exclusively release monomeric GlcNAc from chitin
[22], which is another advantageous aspect of chitin
compared to cellulose. Nevertheless, this raw material has
not been adequately used. Therefore, the basic premise of
this study was to exploit the potential of a saprophytic fun-
gus to degrade the cheap biowaste chitin to its monomer
GlcNAc and to further metabolize this product to NeuNAc.
Results and Discussion
Engineering a NeuNAc synthesis pathway into Hypocrea
The biosynthesis of NeuNAc begins with the formation
of N-acetylmannosamine (ManNAc) from GlcNAc or
UDP-N-acetylglucosamine (UDP-GlcNAc). In mammals,
ManNAc is then phosphorylated to give ManNAc-6-
phosphate (ManNAc-6P). The second step involves the
condensation of either ManNAc (in bacteria) or Mac-
NAc-6P (in mammals) with phosphoenolpyruvate (PEP)
to give NeuNAc or NeuNAc-9P, respectively. In mam-
mals, NeuNAc-9P is then dephosphorylated to generate
NeuNAc (see Figure 1). Hypocrea naturally degrades
chitin almost exclusively to GlcNAc [22]. Therefore, the
challenge was to engineer a pathway to convert GlcNAc
to NeuNAc via ManNAc, which would enable the use of
Hypocrea as a whole-cell catalyst.
Lee and coworkers found that whole-cell extracts of sev-
eral photobacteria could convert GlcNAc to ManNAc
[13]. Among them, Anabaena sp. CH1 exhibited the high-
est GlcNAc 2-epimerase activity; consequently, they
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Figure 1 An illustration of the NeuNAc synthesis-related pathways in microorganisms. Boxes represent substances or metabolites, ellipses
represent general biochemical processes, black solid lines represent enzymatic reactions in H. jecorina, black dashed lines represent pathways
involving more than one enzymatic reaction in H. jecorina, red lines represent enzyme reactions not occurring in H. jecorina, and blue lines
represent heterologously expressed bacterial enzymes. *EC numbers EC 5.1.3.8 (GlcNAc-2-epimerase) and EC 2.5.1.56 (NeuNAc synthase) refer to
bacterial enzymes that were heterologously expressed using Hypocrea codon-optimized genes. EC 4.1.3.20, N-acylneuraminate-9-phosphate
synthase; EC 3.1.3.29, N-acylneuraminate-9-phosphatase; EC 2.7.1.60, N-acylmannosamine kinase; EC 5.1.3.14, UDP-N-acetylglucosamine 2-
epimerase; EC 5.4.2.3 Phosphoacetylglucosamine mutase; EC 2.7.7.23, UDP-N-GlcNAc diphosphorylase; EC2.7.1.59, N-acetylglucosamine kinase;
GlcNAc, N-acetylglucosamine; ManNAc, N-acetylmannosamine; NeuNAc, N-acetylneuraminic acid; P, phosphate group.
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merase from Anabaena sp. CH1 (E.C. 5.1.3.8), which was
used in the present study as a Hypocrea codon-optimized
gene. For the second step (the condensation of ManNAc
to NeuNAc), the currently used enzyme-catalyzed pro-
cesses use a lyase, which requires an excess of pyruvate.
U s eo ft h i si n c u r sh i g hd o w n s t r e a mp r o c e s s i n gc o s t s .
Therefore, we used the NeuNAc synthase (EC 2.5.1.56)
from Campylobacter jejuni [23] in the Hyprocrea process.
This enzymatic step entails the use of PEP instead of pyru-
vate, which in the intended in vivo process is supplied by
the fungus, thereby leading to an irreversible and more
efficient reaction towards NeuNAc [24]. Moreover, the
need for an excess of pyruvate becomes obsolete, and the
resulting downstream process is significantly simplified.
Similar to the GlcNAc 2-epimerase, the coding sequence
for the NeuNAc synthase was codon-optimized for the
usage in Hypocrea. The synthetic pathway is presented in
Figure 1. The complete nucleotide sequences for both
genes encoding the recombinant enzymes, tbage and
tneub, are shown in additional file 1.
Metabolization or uptake of NeuNAc can not be observed
in Hypocrea
As the ability of the fungus to metabolize NeuNAc is an
important issue, a possible uptake of NeuNAc by H. jecor-
ina was investigated. Therefore, the fungus was pre-grown
on glycerol in liquid culture, and half of the mycelium was
autoclaved and half of it was harvested. The dead and liv-
ing mycelia were transferred to glycerol-containing med-
ium to study growth conditions or to medium without a
carbon source to study resting cell conditions. NeuNAc
was added to both media, and cultures were incubated for
8 h. Supernatants from all conditions were analyzed after
incubation for 0 and 8 h by HPLC after derivatization
using 1,2-diamino-4,5-methylenedioxybenzene dihy-
drochloride (DMB). Similar amounts of NeuNAc were
present under all conditions regardless of whether the fun-
gus was alive or dead (Figure 2a). This result indicates that
NeuNAc uptake does not occur in H. jecorina. As a posi-
tive control experiment we did a similar experiment but
instead of NeuNAc, GlcNAc was added to the media. As
can be inferred from Figure 2b GlcNAc was completely
consumed after eight hours under both growth and resting
cell conditions when the mycelium was viable.
Characterization of the recombinant H. jecorina strain
Recombinant Hypocrea strains were generated using pro-
toplast transformation of H. jecorina QM9414. In the
derived strains, the two Hypocrea codon-optimized genes
(without GST-tag) were placed under the control of either
the H. jecorina pyruvate kinase (pki) promoter, which is a
strong constitutive promoter, or the H. jecorina xylanase 1
(xyn1) promoter, which is a strict shut-off system if an
inducer (e.g. D-xylose) is missing. Such a system was used
to avoid interference of the introduced recombinant path-
way with cell wall biosynthesis and consequently, biomass
formation. However, when comparing both promoter sys-
tems the strong pki promoter did not lead to decreased
growth, diminished cell integrity or other adverse effects
(data not shown). Therefore, we used strains in which
both genes were under the control of the pki promoter for
further studies as we observed a remarkably higher Neu-
NAc formation.
Transcriptional analysis of the recombinant H. jecorina
strains was done by RT-qPCR to compare expression of
both inserted genes using sar1 (SAR/ARF-type small
GTPase) as a stable reference gene [25]. Furthermore, the
copy numbers of both genes was measured by qPCR of
genomic DNA using pki as a reference, which in the native
H. jecorina genome is present as a single copy gene. Based
on these analyses a strain (termed PEC/PSC1) was chosen
for further investigations because it showed the highest
equal expression of both inserted genes. This was con-
firmed by the finding that this strain bears two copies of
each recombinant gene in the genome. These data were
also supported using Southern blot analysis (data not
shown).
GlcNAc 2-epimerase and NeuNAc synthase are fully
functional as GST-fusion proteins
Both recombinant enzymes were heterologously
expressed as glutathione S-transferase (GST) fusion pro-
teins in E. coli; the affinity chromatography purified pro-
teins were used to confirm that their enzymatic
capability was not altered by the codon usage adaptation
and to provide a positive control for the enzymatic
assays later on.
To determine if the recombinant enzymes were func-
tional, both GST fusion proteins were used in an enzy-
m a t i ca s s a y .T h ep r e s e n c eo fG l c N A ca n dt h ef o r m a t i o n
of the intermediate product ManNAc and the final pro-
duct NeuNAc were monitored using HPLC-MS analysis
and results are presented in Figure 3. Application of the
GST-fusion proteins of both enzymes in the in vitro assay
led to the formation of ManNAc and NeuNAc demon-
strating that the synthetic genes are expressed as func-
tional proteins (Figure 3a1 and 3b1).
NeuNAc synthesis in vitro by recombinant H. jecorina
strains
According to the GST-fusion proteins, cell-free extracts of
the recombinant H. jecorina strain PEC/PSC1 were
applied in the enzymatic assay. The formation of ManNAc
(Figure 3a2) and NeuNAc could be detected (Figure 3b2).
This demonstrates that both enzymes are also fully func-
tionally expressed in the recombinant H. jecorina strain
PEC/PSC1. Neither ManNAc nor NeuNAc was detected
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assay (Figure 3a3 and 3b3), indicating that these pathways
are normally not active in Hypocrea.
To investigate the stability of NeuNAc in cell-free
extracts of the recombinant strain, according cell-free
extracts obtained from the cultivation in a bioreactor on
chitin (vide infra)w e r es p i k e dw i t hN e u N A ca n di n c u -
bated for 24 h. As a control, a heat-inactivated cell-free
extract was similarly treated. Using HPLC analysis after
derivatization with DMB, similar amounts of NeuNAc
were detected in both extract preparations (Figure 3c),
suggesting that components of the cell-free extract do
not actively degrade NeuNAc. In addition, a similar
amount of NeuNAc was measured in a NeuNAc-spiked
cell-free extract of the recombinant strain that was not
incubated, assuming that the 24-h incubation period at
30°C did not decrease the NeuNAc levels. As a final
control, a cell-free extract without NeuNAc was also
analyzed after a 24-h incubation period and, as
expected, showed a lower amount of NeuNAc, which
could only have resulted from its formation during the
cultivation on chitin. In summary, we did not observe
degradation of NeuNAc by H. jecorina. These data sug-
gest that NeuNAc is not metabolized by the recombi-
nant Hypocrea strain.
NeuNAc synthesis in vivo by the recombinant H. jecorina
strain
We next addressed whether the recombinant H. jecorina
strain had the ability to produce NeuNAc in vivo.T ot e s t
this, the strain was grown on GlcNAc in shake flasks and
cultivated on colloidal chitin in a bioreactor. Data on the
corresponding cultivation monitoring are provided in
additional file 2. As a positive control, an enzyme assay
using the GST fusion proteins was again performed and
resulted in the detection of ManNAc using HPLC-MS
analysis as shown in Figure 4a1. Notably, the intermedi-
ate ManNAc was detected in the recombinant strain,
regardless of the carbon source (Figure 4a2 und Figure
4a4), whereas the parental strain did not form ManNAc
(Figure 4a3). In the parental strain, only the first metabo-
lite, GlcNAc, was detected, and it was present because it
was either directly used as a carbon source or formed by
degradation of the biopolymer chitin due to the native
chitinolytic activity of the fungus. The synthesis of the
product NeuNAc was analyzed using HPLC-MS/MS ana-
lysis (Figure 4b). As a positive control, the reaction pro-
ducts (ManNAc, NeuNAc) generated by the use of the
GST fusion proteins in an enzymatic assay are shown
(Figure 4b1). Importantly, the recombinant H. jecorina
strain formed NeuNAc using either carbon source,
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Figure 2 The analysis of possible metabolization of NeuNAc in H. jecorina. The parental strain was pre-cultured on glycerol, and half of the
mycelia were autoclaved. Living (light grey) and dead (dark grey) mycelia were transferred to MA media containing glycerol or MA media that
lacked a carbon source, and NeuNAc (a) or GlcNAc (b) (as positive control) was added to both media. Samples were collected at 0 and 8 h. For
NeuNAc analysis supernatants were derivatized using DMB befor analyses using HPLC. The presented values are the means of two biological
duplicates that were derivatized in duplicate. Error bars indicate the standard deviations.
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+ ion. Retention times (RTs) of ManAc (12.288 min) and GlcNAc (12.988
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extract of the parental strain. (b) EICs at 310.1134 amu, corresponding to the mass of the [NeuNAc+H]
+ ion. RT of NeuNAc (8.348 min) is
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the in vitro assay using a cell-free extract of the PEC/PSC1 strain showing an 8-fold amplification compared to (1). (3) Chromatogram of a cell-
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NeuNAc and incubated for 0 and 24 h. A heat-inactivated cell-free extract was similarly treated. An active cell-free extract without NeuNAc
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indicate standard deviations.
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Page 5 of 9GlcNAc or chitin (Figure 4b2 and 4b4), whereas in the
parental strain no formation of NeuNAc was detected
(Figure 4b3). This analysis allowed us to estimate that
13 μg NeuNAc per g mycelium (dry weight) was formed
in the recombinant strain. Thus, on its own, this would
not be a competitive production process, but it does
demonstrate the possibility for engineering a saprophyte
and using it as a whole-cell catalyst that expresses a
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potential considering its use of a cheap starting material
and the relatively simple, inexpensive cultivation of a
fungus.
Conclusions
Taken together, we successfully engineered Hypocrea in a
way that this fungus now produces NeuNAc from the bio-
polymer chitin by employing its natural saprophytic activ-
ity in combination with the introduction of a bacterial
enzyme cascade. Because human society will face severe
bottlenecks in the supply of energy and in obtaining cer-
tain raw materials in the upcoming years, we hope that
this study will highlight the potential advantages of biopo-
lymers, such as chitin, and stimulate their efficient usage.
Furthermore, we anticipate that such strategies will sup-
port efforts to create sustainable production processes.
Methods
Strains and cultivation conditions
The parental strain H. jecorina (T. reesei [26]) QM9414
(ATCC 26921) was maintained on malt extract (MEX)
agar.
Mycelia for the enzymatic assay were cultivated in 3%
(w/v) MEX medium using 10
8 conidia/L at 30°C.
Cultivation of H. jecorina on colloidal chitin was per-
formed in a bench top bioreactor (Bioengineering, Wald,
Switzerland) as previously described [27]. Briefly, 500 mL
Mandels-Andreotti (MA) [28] medium containing 1%
(w/v) colloidal chitin [29], 0.5% GlcNAc, and 0.1% (w/v)
b a c t op e p t o n e( D i f c o ,D e t r o i t ,U S )w a si n o c u l a t e dw i t h
10
8 conidia/L. Some drops glanapon (Becker, Wien,
Austria) were added to the medium to avoid excessive
foam formation. Cultivation was performed at 30°C tem-
perature, pH 5, 0.3 vvm aeration rate, and 500 rpm agita-
tion rate for 96 h. Each sample drawing was followed by a
microscopic analysis for infection control. Culture super-
natant and mycelia were separated by filtration through
GF/F glass microfiber filters (Whatman, Brentford, UK).
All strains (parental, recombinant) showed similar growth
on rich media as well as MA medium.
Plasmid construction
The synthetic gene tbage (for sequence see additional file
1) is based on the protein sequence of Anabaena sp. CH1
GlcNAc-2-epimerase (GenBank: ABG57042) and was
reverse translated into a nucleotide sequence using the
GeneOptimizer
® software (Geneart, Regensburg, Ger-
many). The codon usage was optimized for H. jecorina
(http://www.kazusa.or.jp/codon). The synthetic gene tneub
(for sequence see additional file 1) was similarly obtained
based on the protein sequence from Campylobacter jejuni
NCTC11168 NeuNAc synthase (http://old.genedb.org/
genedb/cjejuni/index.jsp, Cj1141).
The synthetic genes tbage and tneub were excised
from the production plasmid using XbaI/NsiId i g e s t i o n
and inserted into pRLMex30 [30] to generate the plas-
mids pMS-PEC and pMS-PSC.
For the construction of pGEX-epi and pGEX-syn, the
oligonucleotides GEXfw and GEXrev (Table 1) were
used to introduce an XbaIa n dNsiI site into plasmid
pGEX4T-2 (GE Healthcare, Chalfont St Giles, UK),
yielding pGEX-MS. tbage and tneub were inserted into
pGEX-MS via XbaI/NsiI digestion to yield the plasmids
pGEX-epi and pGEX-syn.
Protoplast transformation
The protoplast transformation of H. jecorina was per-
formed as described previously [31]. The plasmid pHylox2
(2 μg) [32], which confers hygromycin B resistance [30],
and 4 μg of each plasmid pMS-PEC and pMS-PSC were
co-transformed into the fungal genome.
DNA analysis
Fungal genomic DNA was isolated as described pre-
viously [31]. Southern hybridization and detection were
performed using the DIG High Prime DNA Labeling
and Detection Starter Kit II following the manufacturer’s
instructions (Roche, Basel, Switzerland).
Transcriptional analysis
RNA extraction, cDNA synthesis and qPCR analysis
were performed as described elsewhere [25]. Primer
sequences are given in Table 1.
Glutathione S-transferase (GST) fusion proteins
GST fusion proteins of GlcNAc-2-epimerase and Neu-
NAc synthase were generated using plasmids pGEX-epi
and pGEX-syn in E. coli BL21 (DE3). Purification of the
proteins was performed using GSTrap™FF (GE Health-
care) according to standard procedures.
Table 1 Oligonucleotides used during this study
Name Sequence (5’®3’) Usage
NANASfw GTGGTGTGCAGGAGGACGAA qPCR tneub
NANASrev CAAGCACATCGCCCAGTTCAAG qPCR tneub
ManEfw GCGATCTTGAGCCAGTTCTC qPCR tbage
ManErev GCTACTTCACCTGCCTCGAC qPCR tbage
GEX-MSfw AATTCCTTCTAGAGATATGCATC Construction pGEX-MS
GEX-MSrev TCGAGATGCATATCTCTAGAAGG Construction pGEX-MS
pkifw R CTGCGACACTCAGAACATGTACGT qPCR pki cDNA
pkifw D GCTCTGCTTGGAACCTGATTGA qPCR pki DNA
pkirev GGTCTGGTCGTCCTTGATGCT qPCR pki
sar1fw TGGATCGTCAACTGGTTCTACGA qPCR sar1
sar1rev GCATGTGTAGCAACGTGGTCTTT qPCR sar1
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Harvested mycelia were ground into fine powder and
resuspended in 0.1 M Bicine buffer (pH 8) containing pro-
tease inhibitors (2 μMl e u p e p t i n ,1μM pepstatin A, and
10 μM PMSF) (0.3 g mycelia/mL). The suspension was
sonicated using a Sonifier
® 250 Cell Disruptor (Branson,
Danbury, US) (power 40%, duty cycle 50%, power 20 sec,
40 sec pause, 10 cycles). Insoluble compounds were sepa-
rated using centrifugation (10 min, 13000 g, 4°C). Enzy-
matic analysis was performed according to a previously
described modified protocol [33]. The assay was per-
formed in a total volume of 100 μL containing 10 mM
GlcNAc, 10 mM PEP, 12.5 mM MnCl2, 100 mM Bicine
buffer (pH 8) and 40 μL cell-free extract. Reactions were
incubated for 60 min at 37°C, terminated at 85°C for
10 min and analyzed using HPLC. As a positive control,
5 μL of both GST fusion proteins were applied in place of
the cell-free extracts.
The stability of NeuNAc in the cell-free extract was
determined by adding NeuNAc (150 μM) and incubat-
ing for 24 h at 30°C. After derivatization with DMB
[34], the NeuNAc quantity was measured using HPLC.
Detection of NeuNAc synthesis in vivo
Harvested H. jecorina mycelia were ground into fine pow-
der and resuspended in water (0.3 g mycelia/mL). The sus-
pension was sonicated using a Sonifier
® 250 Cell Disruptor
(Branson) (power 70%, duty cycle 50%, power for 1 min,
1 min pause, 3 cycles). Insoluble compounds were sepa-
rated using centrifugation (10 min, 13000 g, 4°C), and the
supernatant was analyzed using HPLC-MS/MS.
NeuNAc and GlcNAc uptake
H. jecorina mycelia were pre-grown on MA containing
1% glycerol, transferred to MA medium containing 1%
glycerol or no carbon source, spiked with 30 μMN e u -
NAc or GlcNAc, respectively, and incubated for 8 h at
30°C. Autoclaved mycelia served as a negative control.
After derivatization with DMB [34], the NeuNAc quan-
tity was measured using HPLC.
HPLC and HPLC-MS/MS analysis
NeuNAc, ManNAc and GlcNAc formation was measured
using LC-MS (IT-TOF-MS) (Shimadzu, Kyoto, Japan)
with a Rezex™ RHM-Monosaccharide H
+-column (8%,
300 × 7.8 mm) (Phenomenex, Torrance, USA). The
mobile phase consisted of water with 0.1% (v/v) trifluor-
oacetic acid, the flow was 0.6 mL/min, the column tem-
perature was 80°C, and the injected volume was 10 μL.
MS detection was performed in ESI+ mode, covering a
scan range of 60-600 amu. The retention times were
determined using pure standard substances. The identity
of NeuNAc was confirmed by both, chromatographic
retention time and mass spectral signal, which are very
well matched by authentic standards of NeuNAc. The
better the mass accuracy obtained from exact mass deter-
mination by HR-MS, the lower is the number of possible
isobaric candidates (e.g. [35]). In this case the mass accu-
racy is better than 2 ppm, leading to the number of can-
didates reduced to less than 10, with an even further
reduction in the number of potential candidates because
the isotopic pattern is also taken into account (what the
software of the used IT-TOF-MS instrument does
automatically).
DMB derivatives of NeuNAc were separated on a
Kinetex RP C18 (Phenomenex) at 0.75 mL/min with a
40°C column temperature and a mobile phase of water:
methanol:trifluoroacetic acid (74.25:25:0.75). A Shi-
madzu RF-20AXS fluorescence detector (excitation 373
nm, emission 448 nm) was used for detection.
Additional material
Additional file 1: Coding sequences of the synthetic genes tbage
and tneub. Coding sequences of the synthetic genes tbage and tneub.
The sequences are provided in FASTA format. The XbaI site is underlined,
and the NsiI site is double-underlined. The start codon ATG and the stop
codon TAA are presented in bold letters.
Additional file 2: Parameters of H. jecorina cultivation on chitin in a
bioreactor. Oxygen consumption (pO2; blue line), consumption of the
intermediate N-acetylglucosamine (GlcNAc; red line), formation of the
product N-acetylneuraminic acid (NeuNAc; pink line), and formation of
biomass (given as dry weight, BDW; green line) of the H. jecorina PEC/
PSC1 strain cultivated on chitin in a bioreactor for 96 h are displayed.
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